ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
31.39
+0.40 (1.29%)
Aug 11, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.46 billion as of August 12, 2026. Its market cap has increased by 121.46% in one year.
Market Cap
1.46B
Enterprise Value
1.14B
1-Year Change
121.46%
Ranking
Category
Stock Price
$31.39
ChartMarket Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.46B, an increase of 154.16%. That is a compound annual growth rate of 44.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 1.46B | 76.02% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avalyn Pharma | 1.53B |
| Absci | 1.53B |
| Obsidian Therapeutics | 1.52B |
| Maze Therapeutics | 1.51B |
| Vir Biotechnology | 1.50B |
| Innoviva | 1.49B |
| Savara | 1.45B |
| MoonLake Immunotherapeutics | 1.43B |